近日，全球的新闻媒体都对法国医疗科技初创公司 AZmed 进行了广泛报道。该公司宣布已成功获得 1500 万欧元的 A 轮融资，这一轮的投资者阵容强大，包括了 Maison Worms、Techstars 和 Tempact Ventures 等知名投资机构。
值得注意的是，AZmed 的这笔融资并不是单次性质的，而是对其研发人工智能软件的持续投入。这款名为 Rayvolve 的软件是该公司的主打产品，它利用先进的人工智能技术，致力于提高放射诊断的准确性和效率。
Rayvolve 是一款能够识别标准放射照相中的各种异常情况的辅助工具，这大大减轻了放射科医生和急诊医生的工作负担，使得检查解释更加高效，同时也降低了诊断错误的风险。这种创新性的技术在医学界引起了极大的震撼，也让 AZmed 在短时间内获得了业界的广泛关注。
对于此次融资，AZmed 的创始人兼 CEO 表示：“我们非常高兴能够获得这次融资，这对我们的公司来说是一个重大的里程碑。我们的团队一直在努力开发创新的技术，以改善医疗行业的现状。现在，我们有了足够的资金来扩大我们的业务，并让更多的医院和个人接触到我们的产品。”
未来，AZmed 将继续致力于改进和创新其人工智能软件，为医疗行业带来更多的可能性。而这一切的发生，都源于他们对于技术的坚持和对于未来的信心。
总的来说，AZmed 的这个消息不仅对这家公司本身是一个巨大的鼓舞，更是对整个医疗科技行业的一个好消息。我们可以期待，在不久的将来，AZmed 将会用他们的技术和专业知识，为我们提供更好的医疗服务。
英语如下：
News title: AI medical imaging software startup company AZmed bags 15 million euros in Series A round, set to change the field of medical imaging!
Keywords: AZmed, funding, artificial intelligence, medical imaging
News content: Recently, global news media have widely reported on French healthcare technology startup AZmed’s 15 million euros in Series A financing. The investors of this round include well-known investment institutions such as Maison Worms, Techstars, and Tempact Ventures.
It is noteworthy that AZmed’s financing is not a one-time event, but rather an ongoing investment in its development of artificial intelligence software. The company’s main product is called Rayvolve, which uses advanced artificial intelligence technology to improve the accuracy and efficiency of radiological diagnosis.
Rayvolve is an auxiliary tool that can identify various abnormalities in standard radiographs, significantly lightening the workload of radiologists and emergency doctors, making the examination and interpretation more efficient while reducing the risk of diagnostic errors. This innovative technology has caused a great shock in the medical field, resulting in extensive attention from the industry in a short period of time.
For this round of financing, AZmed’s founder and CEO said: “We are delighted to have received this financing, which is a significant milestone for our company. Our team has always been working hard to develop innovative technology to improve the medical industry. Now, we have enough funds to expand our business and get our product to more hospitals and individuals.”
In the future, AZmed will continue to improve and innovate its artificial intelligence software, bringing more possibilities to the medical field. And everything that has happened is due to the persistence and confidence in the future.
Overall, AZmed’s news is not only a huge boost for itself, but also for the entire healthcare technology industry. We can look forward to the day when AZmed will use their technology and expertise to provide better medical services for us.
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 1